CCP
MDT icon

Corient Capital Partners’s Medtronic MDT Stock Holding History

Corient Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$9.15M Hold
101,932
– – 0.68% 30
2022
Q2 		$9.15M Sell
101,932
-5,314
-5% -$538K 0.69% 32
2022
Q1 		$11.9M Buy
107,246
+579
+0.5% +$61.2K 0.79% 20
2021
Q4 		$11M Buy
106,667
+8,450
+9% +$978K 0.73% 22
2021
Q3 		$12.3M Buy
98,217
+11,609
+13% +$1.5M 0.9% 15
2021
Q2 		$10.8M Buy
86,608
+11,254
+15% +$1.41M 0.79% 18
2021
Q1 		$8.9M Buy
75,354
+1,553
+2% +$182K 0.76% 18
2020
Q4 		$8.64M Buy
73,801
+1,274
+2% +$140K 0.86% 18
2020
Q3 		$7.54M Buy
72,527
+1,316
+2% +$132K 0.87% 18
2020
Q2 		$6.53M Buy
71,211
+15,996
+29% +$1.53M 0.8% 26
2020
Q1 		$4.98M Sell
55,215
-3,060
-5% -$326K 0.79% 28
2019
Q4 		$6.61M Buy
58,275
+1,465
+3% +$161K 0.84% 20
2019
Q3 		$6.17M Buy
56,810
+1,856
+3% +$194K 0.87% 18
2019
Q2 		$5.35M Buy
54,954
+476
+0.9% +$43.5K 0.82% 18
2019
Q1 		$4.96M Sell
54,478
-3,938
-7% -$352K 0.81% 18
2018
Q4 		$5.31M Buy
58,416
+26,518
+83% +$2.48M 0.95% 14
2018
Q3 		$3.14M Hold
31,898
– – 0.52% 47
2018
Q2 		$2.73M Buy
31,898
+9,580
+43% +$800K 0.48% 64
2018
Q1 		$1.79M Buy
22,318
+3,604
+19% +$297K 0.33% 88
2017
Q4 		$1.51M Buy
18,714
+1,685
+10% +$135K 0.26% 97
2017
Q3 		$1.32M Sell
17,029
-5
-0% -$415 0.25% 98
2017
Q2 		$1.51M Buy
17,034
+1,120
+7% +$94.4K 0.23% 110
2017
Q1 		$1.28M Buy
15,914
+3,255
+26% +$254K 0.2% 119
2016
Q4 		$902K Sell
12,659
-1,860
-13% -$146K 0.16% 138
2016
Q3 		$1.25M Buy
+14,519
New +$1.27M 0.23% 110

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Corient Capital Partners's MDT Position: Q3 2022 in Review

Corient Capital Partners held its Medtronic (MDT) position steady in Q3 2022 at 101,932 shares worth $9.15M. The position accounts for 0.68% of the portfolio, ranked #30.

Corient Capital Partners first reported a position in MDT in Q3 2016 and has held it in 25 quarters since. The position peaked at $12.3M in Q3 2021. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Corient Capital Partners held 101,932 shares of Medtronic worth $9.15M as of Q3 2022.
  • Corient Capital Partners left its Medtronic share count unchanged in Q3 2022.
  • Medtronic made up 0.68% of Corient Capital Partners's portfolio in Q3 2022, its #30 holding.
  • Corient Capital Partners first reported a position in Medtronic in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's Medtronic position peaked at $12.3M in Q3 2021.
  • 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.